On May 28, 2025, Envoy Medical, Inc. held its Annual Meeting where stockholders approved an amendment to the 2023 Equity Incentive Plan allowing 1,500,000 shares for issuance, elected two directors, and ratified Grant Thornton LLP as their accounting firm for 2025.